Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMEGA: Omega-3-Fatty Acid Ethyl Esters in Acute Myocardial Infarction Survivors
NCT00251134Phase 3Completed
- Sponsor
- Institut für Herzinfarktforschung
- Start
- Oct 2003
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Zodin with Placebo (2 arms). Primary endpoint: Sudden cardiac death at 12 months. Started Oct 2003; status: completed.
02
Drugs
omega-3-acid ethyl ester
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00251134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251134.